Compare FENC & PBFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FENC | PBFS |
|---|---|---|
| Founded | 1996 | 1889 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.3M | 435.7M |
| IPO Year | 2010 | 2019 |
| Metric | FENC | PBFS |
|---|---|---|
| Price | $10.76 | $18.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 243.7K | 9.3K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.07 |
| EPS | 0.06 | ★ 0.36 |
| Revenue | ★ $44,642,000.00 | $15,814,000.00 |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | N/A |
| P/E Ratio | $179.67 | ★ $50.17 |
| Revenue Growth | N/A | ★ 5.76 |
| 52 Week Low | $5.65 | $12.64 |
| 52 Week High | $13.25 | $19.91 |
| Indicator | FENC | PBFS |
|---|---|---|
| Relative Strength Index (RSI) | 40.04 | 60.33 |
| Support Level | $9.74 | $17.02 |
| Resistance Level | $11.28 | $18.33 |
| Average True Range (ATR) | 0.58 | 0.50 |
| MACD | -0.24 | 0.01 |
| Stochastic Oscillator | 19.77 | 35.23 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.